EMA Authorised: Marixino (previously Maruxa) (memantine hydrochloride) — KRKA, d.d.

View source ↗

Summary

Authorised medicinal product Marixino (memantine hydrochloride) for Alzheimer disease in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Marixino (memantine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: KRKA, d.d.. Decision date: 06/12/2021